Literature DB >> 34221681

In vivo photoacoustic imaging for monitoring treatment outcome of corneal neovascularization with metformin eye drops.

Kwok-Ho Lui1,2, Shiying Li1,2, Wai-Sum Lo1, Yanjuan Gu1, Wing-Tak Wong1,3.   

Abstract

Corneal neovascularization (CNV) compromises corneal avascularity and visual acuity. Current clinical visualization approaches are subjective and unable to provide molecular information. Photoacoustic (PA) imaging offers an objective and non-invasive way for angiogenesis investigation through hemodynamic and oxygen saturation level (sO2) quantification. Here, we demonstrate the utility of PA and slit lamp microscope for in vivo rat CNV model. PA images revealed untreated corneas exhibited higher sO2 level than treatment groups. The PA results complement with the color image obtained with slit lamp. These data suggest PA could offer an objective and non-invasive method for monitoring CNV progression and treatment outcome through the sO2 quantification.
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Entities:  

Year:  2021        PMID: 34221681      PMCID: PMC8221937          DOI: 10.1364/BOE.423982

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  45 in total

1.  Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization.

Authors:  Natasha Spiteri; Vito Romano; Yalin Zheng; Sohraab Yadav; Rahul Dwivedi; Jern Chen; Sajjad Ahmad; Colin E Willoughby; Stephen B Kaye
Journal:  Ophthalmology       Date:  2015-04-01       Impact factor: 12.079

Review 2.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

Review 3.  Molecular underpinnings of corneal angiogenesis: advances over the past decade.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  In vivo photoacoustic imaging of chorioretinal oxygen gradients.

Authors:  Ali Hariri; Junxin Wang; Yeji Kim; Anamik Jhunjhunwala; Daniel L Chao; Jesse V Jokerst
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

5.  Retinal oxygen saturation is altered in diabetic retinopathy.

Authors:  Sveinn Hakon Hardarson; Einar Stefánsson
Journal:  Br J Ophthalmol       Date:  2011-11-11       Impact factor: 4.638

6.  Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.

Authors:  Ramandeep Rattan; Rondell P Graham; Jacie L Maguire; Shailendra Giri; Viji Shridhar
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

7.  Nanoparticle Regrowth Enhances Photoacoustic Signals of Semiconducting Macromolecular Probe for In Vivo Imaging.

Authors:  Chen Xie; Xu Zhen; Yan Lyu; Kanyi Pu
Journal:  Adv Mater       Date:  2017-10-11       Impact factor: 30.849

8.  In Vivo Photoacoustic Imaging of Anterior Ocular Vasculature: A Random Sample Consensus Approach.

Authors:  Seungwan Jeon; Hyun Beom Song; Jaewoo Kim; Byung Joo Lee; Ravi Managuli; Jin Hyoung Kim; Jeong Hun Kim; Chulhong Kim
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

9.  Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo.

Authors:  Jing Han; Yue Li; Xiuli Liu; Tongrong Zhou; Haijing Sun; Paul Edwards; Hua Gao; Fu-Shin Yu; Xiaoxi Qiao
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

10.  Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization.

Authors:  Ji-Chang Wang; Xin Sun; Qiang Ma; Gui-Feng Fu; Long-Long Cong; Hong Zhang; De-Fu Fan; Jun Feng; Shao-Ying Lu; Jian-Lin Liu; Guang-Yue Li; Pei-Jun Liu
Journal:  J Cell Mol Med       Date:  2018-05-04       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.